Gastrointestinal involvement in patients affected with 22q11.2 deletion syndrome
Authors:
- Giuliana GiardinoGGGiuliana Giardino
- Emilia CirilloECEmilia Cirillo
- Filomena MaioFMFilomena Maio
- Vera GalloVGVera Gallo
- Tiziana EspositoTETiziana Esposito
- Roberta NaddeiRNRoberta Naddei
- Fiorentino GrassoFGFiorentino Grasso
- Claudio PignataCPClaudio Pignata
- 16 December 2013
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 49 (3) , 274-279
Abstract
OBJECTIVE. Enteropathy is a very common feature in patients with primary immunodeficiencies. In patients with Del22 gastrointestinal (GI) alterations, including feeding disorders and congenital abnormalities have been often reported, mostly in the first year of life. MATERIAL AND METHODS. Aim of this monocentric study is to better define the GI involvement in a cohort of 26 patients affected with Del22 syndrome. Anamnestic information was retrospectively collected for each patient. Weight and height parameters at the time of the screening were recorded. Plasma levels of hemoglobin, iron, ferritin, albumin, total protein, calcium, phosphorus, transaminase levels, antigliadin (AGA) IgA and IgG, and antitissue transglutaminase (anti-TGase) titers were measured. RESULTS. A GI involvement was identified in the 58% of patients. The prominent problems were abdominal pain, vomiting, gastroesophageal reflux and chronic constipation. Weight deficiency, short stature and failure to thrive were reported in 54, 42, and 30% of the patients, respectively. The evidence of sideropenic anemia, in keeping with hypoproteinemia, impaired acid steatocrit or cellobiose/mannitol test suggested an abnormal intestinal permeability. In this cohort, a high prevalence of AGA IgA and IgG positivity was observed. Celiac disease (CD) was suspected in three patients, and in one of them confirmed by histology. In this patient, a long-lasting gluten-free diet failed to restore the intestinal architecture. CONCLUSIONS. In conclusion, GI involvement is a very common feature in Del22 patients. A better characterization of GI involvement would be very useful to improve the management of these patients.Keywords
This publication has 17 references indexed in Scilit:
- Positive serum antigliadin antibodies without celiac disease in the elderly population: does it matter?Scandinavian Journal of Gastroenterology, 2010
- Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromesThe Lancet, 2007
- Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes)Current Opinion in Pediatrics, 2002
- Human equivalent of the mouse Nude/SCID phenotype: long-term evaluation of immunologic reconstitution after bone marrow transplantationBlood, 2001
- Auxological evaluation in patients with DiGeorge/velocardiofacial syndrome (deletion 22q11.2 syndrome)Genetics in Medicine, 2001
- Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.Journal of Medical Genetics, 1997
- Congenital alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency in two sibsAmerican Journal of Medical Genetics, 1996
- The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school‐age subjectsActa Paediatrica, 1996
- Coeliac disease in the year 2000: exploring the icebergThe Lancet, 1994
- Anti-gliadin AntibodiesJournal of Pediatric Gastroenterology and Nutrition, 1991